Arbuckle Stuart A's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Feb 28, 2023
- Accession no.
- 0001209191-23-013708
- Filed
- Feb 28, 2023
- Trade date
- Feb 24-27, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $1.45M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Arbuckle Stuart ACIK 0001557290 | Officer (EVP, COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 24, 2023 | Common Stock | FTax withholdingDisposed | −4,714 | $289.12 | −$1,362,911.68 | 61,590 | Direct | |
| Feb 27, 2023 | Common Stock | SSaleDisposed | −3,834 | $287.16F2,F3 | −$1,100,971.44 | 57,756 | Direct | |
| Feb 27, 2023 | Common Stock | SSaleDisposed | −400 | $287.59F2,F4 | −$115,036 | 57,356 | Direct | |
| Feb 27, 2023 | Common Stock | SSaleDisposed | −800 | $288.92F2,F5 | −$231,136 | 56,556 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 3 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $287.16 (range $286.57 to $287.51).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $287.59 (range $287.57 to $287.60).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $288.92 (range $288.57 to $289.38).
Referenced by the price of 1 transaction in Table I.